NVCR
NovoCure Ltd
NovoCure Ltd (NVCR) has 20 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jul 1, 2026.
Insiders have net sold $893K over the trailing 6 months.
- Industry:Medical - Instruments & Supplies
- CEO:Frank Leonard
- Employees:1,488
- HQ:Saint Helier, US
- IPO:2015-10-01
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$893K
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$2.3B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Leonard Frank XFirst filing | Chief Executive Officer | Sale | 34,273 | $615K | Jun 5 | SEC ↗ |
LEUNG GABRIELFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | SEC ↗ |
Stafford KristinFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | SEC ↗ |
Ocean Allyson JFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | SEC ↗ |
VERNON W ANTHONYFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | SEC ↗ |
Scannell Timothy JFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | SEC ↗ |
Hung DavidFirst filing | Director | Sale | 2,945 | $46K | Jun 3 | SEC ↗ |
Related companies
NovoCure Ltd is in the Healthcare sector.